PHARMERIT INTERNATIONAL

Serial Number 87213040
Registration 5304979
702

Registration Progress

Application Filed
Oct 24, 2016
Under Examination
Approved for Publication
Jul 25, 2017
Published for Opposition
Jul 25, 2017
Registered
Oct 10, 2017

Trademark Image

PHARMERIT INTERNATIONAL

Basic Information

Serial Number
87213040
Registration Number
5304979
Filing Date
October 24, 2016
Registration Date
October 10, 2017
Published for Opposition
July 25, 2017
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Oct 8, 2024
Registration
Registered
Classes
042

Rights Holder

Pharmerit International, L.P.

13
Address
4350 East West Highway, Suite 430
Bethesda, MD 20814

Ownership History

Pharmerit International, L.P.

Original Applicant
13
Bethesda, MD

Pharmerit International, L.P.

Owner at Publication
13
Bethesda, MD

Pharmerit International, L.P.

Original Registrant
13
Bethesda, MD

Legal Representation

Attorney
Donna J. Bunton

USPTO Deadlines

Next Deadline
656 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20171010)
Due Date
October 10, 2027
Grace Period Ends
April 10, 2028

Application History

25 events
Date Code Type Description Documents
Oct 8, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Oct 8, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Oct 8, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 10, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 10, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 7, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 6, 2019 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Oct 10, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 25, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 25, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 5, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 17, 2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 9, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 8, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 8, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 2, 2017 ALIE A ASSIGNED TO LIE Loading...
May 9, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 9, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 1, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Feb 1, 2017 GPRA F PRIORITY ACTION E-MAILED Loading...
Feb 1, 2017 CPRA R PRIORITY ACTION WRITTEN Loading...
Feb 1, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 28, 2016 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 27, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 27, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical research in the field of health outcomes
First Use Anywhere: 20050100
First Use in Commerce: 20050100

Additional Information

Design Mark
The mark consists of words "PHARMERIT INTERNATIONAL" in a stylized font presented in a rectangular-shaped design.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The word(s) "PHARMERIT" has no meaning in a foreign language.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INTERNATIONAL"